Skip to main content
大唐药业 logo

大唐药业 — Investor Relations & Filings

Ticker · 920433 Beijing Stock Exchange Manufacturing
Filings indexed 420 across all filing types
Latest filing 2023-04-25 Regulatory Filings
Country CN China
Listing Beijing Stock Exchange 920433

About 大唐药业

http://www.nmdt.com.cn/

Inner Mongolia Datang Pharmaceutical specializes in the research, development, and production of traditional Chinese and Mongolian medicines. The company focuses on modernizing ethnic medicinal formulas through advanced biotechnology and standardized manufacturing processes. Its product portfolio covers therapeutic areas including respiratory health, cardiovascular conditions, and gastrointestinal disorders. Notable offerings include Xuanfei Zhike granules and specialized Mongolian medicinal preparations. The organization integrates traditional knowledge with contemporary clinical research to develop proprietary formulations. By maintaining rigorous quality management systems and investing in automated production lines, the company aims to enhance the efficacy and accessibility of ethnic medicines for a broad patient base.

Recent filings

Filing Released Lang Actions
中泰证券股份有限公司关于内蒙古大唐药业股份有限公司预计2023年日常性关联交易的核查意见
Regulatory Filings Classification · 95% confidence The document is a detailed opinion and review by a sponsoring securities company regarding the expected related party transactions for the year 2023 of Inner Mongolia Datang Pharmaceutical Co., Ltd. It includes information about the nature of the transactions, related parties, pricing policies, internal decision-making procedures, and opinions from independent directors and the sponsor. The document is not a financial report, earnings release, or regulatory filing per se, but rather a formal review and opinion on related party transactions, which is a typical regulatory disclosure related to capital market compliance. It does not fit into categories like Annual Report, Interim Report, or Earnings Release. It is also not a simple announcement or certification. The closest fitting category is Regulatory Filings (RNS), which serves as a fallback for miscellaneous regulatory disclosures that do not fit other specific categories.
2023-04-25 Chinese
关于年度审计机构更正项目质量复核人员信息的公告
Audit Report / Information Classification · 95% confidence The document is an announcement regarding the correction of the project quality review personnel information related to the company's 2021 annual audit. It references the audit firm and the audit personnel but does not contain the audit report itself or detailed financial data. The document is short (1063 characters) and serves to correct previously disclosed audit personnel information. This fits the category of an Audit Report / Information type document, as it relates to audit personnel and quality review but is not a full annual report or financial statement. Therefore, the appropriate classification is AR (Audit Report / Information). FY 2021
2023-02-28 Chinese
关于变更签字注册会计师及项目质量复核人的公告
Audit Report / Information Classification · 95% confidence The document is an announcement regarding the change of the signing certified public accountants and project quality reviewers for the company's 2022 audit. It references the audit firm and personnel changes but does not contain any financial statements or audit results itself. It is not a full audit report but an announcement about audit personnel changes. This fits the category of Audit Report / Information (AR), which includes standalone audit reports and related audit information excluding full annual reports. The document is short and focused on audit personnel changes, not the audit report itself or financial data. FY 2022
2023-02-23 Chinese
2022年年度业绩快报公告
Earnings Release Classification · 95% confidence The document is titled as a 2022 annual performance express report (年度业绩快报公告) and contains preliminary financial data for the year 2022, including revenue, net profit, earnings per share, and asset information. It explicitly states that the data is preliminary and unaudited, and the final audited data will be disclosed in the 2022 annual report. The document is relatively short (1599 characters) and serves as a quick earnings update rather than a full annual report. It does not contain full financial statements or detailed analysis but provides key financial highlights and explanations for performance changes. This matches the characteristics of an Earnings Release (ER) rather than a full Annual Report (10-K) or Interim Report (IR). FY 2022
2023-02-23 Chinese
2022年年度业绩预告公告
Regulatory Filings Classification · 95% confidence The document is an announcement of the company's 2022 annual performance forecast, including preliminary financial data and a comparison with the previous year. It explicitly states that the data is unaudited and that the final audited data will be disclosed in the 2022 annual report. The document is short (829 characters) and serves as a preliminary earnings forecast rather than a full financial report. It does not contain comprehensive financial statements or detailed analysis, so it is not an Annual Report (10-K) or Interim Report (IR). It is also not an Earnings Release (ER) because it is a forecast, not an initial announcement of quarterly or periodical results. Given the nature and length, this fits best as a Regulatory Filing (RNS), which covers miscellaneous regulatory announcements that do not fit other categories.
2023-02-23 Chinese
高级管理人员辞职公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding the resignation of a senior management personnel (vice general manager) from the company. It details the resignation date, reasons, and impact on the company’s board and operations. There is no financial data, no mention of financial results, no regulatory filings or certifications, and no reference to any report publication. The content clearly fits the category of management changes.
2023-02-19 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.